Written by Joshua Belfer
Spoon Feed
A reanalysis of oxygen saturation data from Cochrane meta-analyses reveals multiple critical errors; when corrected, albuterol transiently lowers oxygen saturation in bronchiolitis – aligning with clinical and physiologic observations.
By the way, Dr. Belfer has started a new, dedicated PEM blog called HipPEMcrates.com! Check it out! ~Clay Smith
The meta-analysis got it backwards
Albuterol has long been a controversial topic in bronchiolitis management. Clinical experience and physiologic studies have consistently shown that when used in asthma management, it can cause brief dips in oxygen saturation – likely due to ventilation-perfusion mismatch. The Cochrane reviews on bronchodilators for bronchiolitis, however, suggested the opposite: that albuterol increases oxygen saturation, and this was one of the key findings that shaped guideline recommendations against its use.
In this study, the authors identified numerous errors across all three Cochrane review updates (2006, 2010, 2014) analyzing albuterol’s effect on oxygen saturation in bronchiolitis. These included basic data miscalculations, flipped intervention and placebo group data, and improper inclusion of inpatient studies in outpatient analyses. They also flagged questionable study selections – such as adding oral albuterol to nebulized albuterol analyses and including an extra treatment arm (albuterol + hypertonic saline) from a null study – both of which introduced unnecessary heterogeneity and likely biased the results toward the null. After correcting these flaws, the direction of effect flipped: albuterol slightly decreased oxygen saturation, just as clinicians and physiology studies had observed. The heterogeneity among studies also disappeared with corrections, making the conclusions far more internally consistent.
How does this change my practice?
This reanalysis helps resolve what’s felt like a long-standing disconnect between bedside observations, pulmonary physiology, and evidence-based guidelines. We know that β-agonists like albuterol can cause transient VQ mismatch and brief oxygen desaturation – a phenomenon well supported by physiologic studies. Now, with corrected data, the Cochrane meta-analysis finally reflects that reality. It’s a reminder that when clinical experience and pathophysiology don’t match the literature, it’s worth digging deeper – because sometimes the data, not the practice, is what needs fixing.
Source
Oxygen Saturation Sub-analyses Errors in the Dominant Meta-analysis Used to Deimplement Albuterol as a Therapeutic Option for Bronchiolitis. Pediatr Emerg Care. 2025 Jun 1;41(6):423-428. doi: 10.1097/PEC.0000000000003352. Epub 2025 Feb 24. PMID: 39991968
